Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H7ClO |
| Molecular Weight | 106.551 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC(Cl)=O
InChI
InChIKey=DVECBJCOGJRVPX-UHFFFAOYSA-N
InChI=1S/C4H7ClO/c1-2-3-4(5)6/h2-3H2,1H3
| Molecular Formula | C4H7ClO |
| Molecular Weight | 106.551 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| 1-(4-Bromo-phen-yl)-3-butano-ylthio-urea. | 2010-12-08 |
|
| Acetazolamide-based fungal chitinase inhibitors. | 2010-12-01 |
|
| 1-(4-Acetyl-phen-yl)-3-butyrylthio-urea. | 2008-07-23 |
|
| N-(Benzothia-zol-2-yl)butyramide. | 2008-07-12 |
|
| Ethyl 4-(3-butyrylthio-ureido)benzoate. | 2008-06-28 |
|
| Methyl 3-amino-4-butanamido-5-methyl-benzoate. | 2008-05-14 |
|
| Methyl 4-(butyrylamino)-5-methyl-2-nitro-benzoate. | 2008-03-29 |
|
| 2-Propyl-4H-thia-zolo[3,2-a][1,3,5]triazine-4-thione. | 2008-03-20 |
|
| Water adsorption kinetics and contact angles of pharmaceutical powders. | 2005-04 |
|
| Dibutyrate derivatization of monoacylglycerols for the resolution of regioisomers of oleic, petroselinic, and cis-vaccenic acids. | 2002-01 |
|
| Regiospecific analysis of conifer seed triacylglycerols by gas-liquid chromatography with particular emphasis on delta5-olefinic acids. | 2001-11 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:49:59 GMT 2025
by
admin
on
Mon Mar 31 18:49:59 GMT 2025
|
| Record UNII |
2XVM8E16IR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BUTYRYL CHLORIDE
Created by
admin on Mon Mar 31 18:49:59 GMT 2025 , Edited by admin on Mon Mar 31 18:49:59 GMT 2025
|
PRIMARY | |||
|
141-75-3
Created by
admin on Mon Mar 31 18:49:59 GMT 2025 , Edited by admin on Mon Mar 31 18:49:59 GMT 2025
|
PRIMARY | |||
|
8855
Created by
admin on Mon Mar 31 18:49:59 GMT 2025 , Edited by admin on Mon Mar 31 18:49:59 GMT 2025
|
PRIMARY | |||
|
DTXSID5024710
Created by
admin on Mon Mar 31 18:49:59 GMT 2025 , Edited by admin on Mon Mar 31 18:49:59 GMT 2025
|
PRIMARY | |||
|
2XVM8E16IR
Created by
admin on Mon Mar 31 18:49:59 GMT 2025 , Edited by admin on Mon Mar 31 18:49:59 GMT 2025
|
PRIMARY | |||
|
205-498-5
Created by
admin on Mon Mar 31 18:49:59 GMT 2025 , Edited by admin on Mon Mar 31 18:49:59 GMT 2025
|
PRIMARY | |||
|
m2872
Created by
admin on Mon Mar 31 18:49:59 GMT 2025 , Edited by admin on Mon Mar 31 18:49:59 GMT 2025
|
PRIMARY | Merck Index | ||
|
6016
Created by
admin on Mon Mar 31 18:49:59 GMT 2025 , Edited by admin on Mon Mar 31 18:49:59 GMT 2025
|
PRIMARY |